PM
ZYME icon

Prosight Management’s Zymeworks ZYME Stock Holding History

Prosight Management’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.6M Buy
674,434
+135,385
+25% +$3.44M 3.04% 13
2026
Q1 		$13.5M Buy
539,049
+8,656
+2% +$205K 2.21% 15
2025
Q4 		$14M Sell
530,393
-219,218
-29% -$4.78M 2.89% 16
2025
Q3 		$12.8M Sell
749,611
-560,293
-43% -$8.02M 2.99% 15
2025
Q2 		$16.4M Buy
1,309,904
+352,675
+37% +$4.2M 4.01% 10
2025
Q1 		$11.4M Buy
957,229
+137,229
+17% +$1.87M 3.75% 9
2024
Q4 		$12M Sell
820,000
-97,599
-11% -$1.36M 3.32% 13
2024
Q3 		$11.5M Sell
917,599
-262,401
-22% -$2.86M 2.83% 13
2024
Q2 		$10M Buy
1,180,000
+769,052
+187% +$6.85M 3% 13
2024
Q1 		$4.32M Buy
+410,948
New +$4.56M 1.2% 22
2023
Q4 		– Sell
-106,405
Closed -$675K – 47
2023
Q3 		$675K Buy
+106,405
New +$786K 0.21% 39

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Prosight Management's ZYME Position: Q2 2026 in Review

Prosight Management increased its Zymeworks (ZYME) stake by 25% in Q2 2026, buying an estimated $3.44M and bringing the position to 674,434 shares worth $17.6M. The position accounts for 3.04% of the portfolio, ranked #13.

Prosight Management first reported a position in ZYME in Q3 2023 and has held it in 11 quarters since. 202 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

  • Prosight Management held 674,434 shares of Zymeworks worth $17.6M as of Q2 2026.
  • Prosight Management bought 135,385 Zymeworks shares in Q2 2026, an estimated $3.44M.
  • Zymeworks made up 3.04% of Prosight Management's portfolio in Q2 2026, its #13 holding.
  • Prosight Management first reported a position in Zymeworks in Q3 2023 and has held it in 11 quarters since.
  • 202 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on Prosight Management's 13F filing for Q2 2026, filed 14 Aug 2026.